Related Experiment Video
Updated: Aug 17, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Pain management, including intrathecal pumps
Thomas J Smith1, Craig Swainey, Patrick J Coyne
1Division of Hematology/Oncology and Palliative Care, Massey Cancer Center of Virginia Commonwealth University, MCV Box 980230, Richmond, VA 23298-0230, USA. tsmith@hsc.vcu.edu
Abstract:
Even when managed according to guidelines, approximately 14% of cancer patients have unrelieved pain or unacceptable side effects, and there is good evidence that patients still are not receiving optimal therapy. Implantable drug delivery systems (IDDS) administer small amounts of drugs directly to the spinal cord and reduce systemic narcotic exposure by a factor of 300 to one. In a large randomized trial of 202 patients with pain scores of 7.5 or higher, despite 200 mg or more of morphine or equivalent narcotics, IDDS gave better clinical success than comprehensive medical management (84.5% vs 70.8%, P=0.05). Pain scores were reduced by 52% versus 39%, drug toxicity scores were reduced by 50% versus 17%, and IDDS patients lived longer. Even the most refractory pain patients--those failed by a month of comprehensive medical management by experts--when subsequently provided with IDDS, had a 27% reduction in pain scores and a 50% reduction in drug side effects. Given multiple positive small cohort studies and a positive high-power randomized trial, IDDS should be considered as the best treatment for this population.
Insights
Implantable drug delivery systems (IDDS) offer superior pain relief and reduced side effects for cancer patients compared to standard care. This approach significantly improves outcomes for even the most challenging pain cases.
Area of Science:
- Oncology
- Pain Management
- Neurology
Background:
- Despite current guidelines, 14% of cancer patients experience unrelieved pain or side effects.
- Optimal pain management therapy remains a challenge in oncology care.
Purpose of the Study:
- To evaluate the efficacy of implantable drug delivery systems (IDDS) for managing refractory cancer pain.
- To compare IDDS with comprehensive medical management in a large randomized trial.
Main Methods:
- A randomized trial involving 202 cancer patients with high pain scores (≥7.5) and significant narcotic use.
- Patients received either IDDS or comprehensive medical management.
Main Results:
- IDDS achieved higher clinical success rates (84.5% vs. 70.8%, P=0.05) compared to medical management.
- IDDS significantly reduced pain scores (52% vs. 39%) and drug toxicity (50% vs. 17%).
- IDDS demonstrated improved survival and reduced side effects, even in refractory pain patients.
Conclusions:
- Implantable drug delivery systems represent a superior treatment option for cancer patients with refractory pain.
- IDDS offer better pain control, reduced toxicity, and improved quality of life.
- Evidence from randomized trials supports IDDS as a best treatment for this patient population.
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Analgesia and Pain Management
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Peripheral Artery Disease V: Postoperative Nursing Management

